Christer Nordstedt
Chairman at WNTRESEARCH AB
Christer Nordstedt active positions
| Companies | Position | Start | End |
|---|---|---|---|
| WNTRESEARCH AB | Chairman | 2021-12-31 | - |
| IRLAB THERAPEUTICS AB | Director/Board Member | 2022-12-31 | - |
| Orion Diagnostica AB | Director/Board Member | - | - |
| Fermion Ltd. | Director/Board Member | - | - |
| Snevringe AB | Chairman | - | - |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Chief Executive Officer | 2022-11-30 | - |
Career history of Christer Nordstedt
Former positions of Christer Nordstedt
| Companies | Position | Start | End |
|---|---|---|---|
| VIVESTO AB | Chief Executive Officer | 2022-07-20 | 2022-11-29 |
| ORION OYJ | Chief Tech/Sci/R&D Officer | 2017-02-20 | 2020-03-04 |
Teva GmbH
 Teva GmbH Medical DistributorsDistribution Services Part of Teva Pharmaceutical Industries Ltd., Teva GmbH is a German company that aims to provide high-quality medications to improve the quality of life for patients. The company is based in Ulm, Germany. The CEOs are Andreas Burkhardt, Thomas Andreas Schlenker. The company was founded in 2011 by Chaim Salomon, Günther Friedländer, Moshe Levinson, Yitschak Elstein. | Corporate Officer/Principal | - | - |
Training of Christer Nordstedt
| Karolinska Institutet | Doctorate Degree |
Statistics
International
| Sweden | 8 |
| Finland | 2 |
| Germany | 2 |
Operational
| Director/Board Member | 3 |
| Chairman | 2 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| ORION OYJ | Health Technology |
| WNTRESEARCH AB | Health Technology |
| VIVESTO AB | Health Technology |
| IRLAB THERAPEUTICS AB | Health Technology |
| Private companies | 5 |
|---|---|
Teva GmbH
Teva GmbH Medical DistributorsDistribution Services Part of Teva Pharmaceutical Industries Ltd., Teva GmbH is a German company that aims to provide high-quality medications to improve the quality of life for patients. The company is based in Ulm, Germany. The CEOs are Andreas Burkhardt, Thomas Andreas Schlenker. The company was founded in 2011 by Chaim Salomon, Günther Friedländer, Moshe Levinson, Yitschak Elstein. | Distribution Services |
| Orion Diagnostica AB | |
| Fermion Ltd. | |
| Snevringe AB | |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Health Technology |
- Stock Market
- Insiders
- Christer Nordstedt
- Experience
